Clinical trial
Anastrozole and ZD 1839 in Treating Postmenopausal Women With Metastatic Breast…
NCT00049062 · The University of Texas Health Science Center at San Antonio, Other · Completed
Key facts
| NCT number | NCT00049062 |
|---|---|
| Title | Anastrozole and ZD 1839 in Treating Postmenopausal Women With Metastatic Breast Cancer |
| Official title | A Phase II And Biologic Correlative Study Investigating ARIMIDEX In Combination With IRESSA (ZD1839) In Post-Menopausal Patients With Estrogen Receptor-Positive Metastatic Breast Carcinoma Who Have Previously Failed Hormonal Therapy |
| Lead sponsor | The University of Texas Health Science Center at San Antonio, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | anastrozole, gefitinib |
| Start date | Sep 1, 2002 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Feb 21, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: